Vetter Pharma-Fertigung GmbH & Co. has been granted approval by the FDA for the production of a client’s new drug. The company will begin filling the drug at its Ravensburg Vetter South (RVS) facility. Vetter provides contract manufacturing services for pharmaceutical and biotech companies and specializes in aseptically pre-filled injection systems used in the production of biotechnological and complex medications.
   
“For us, the approval by the FDA is a vital step in our corporate development,” said Thomas Otto, Vetter’s managing director. “It means that we can continue expanding our business. It also secures our jobs, our investments and our future projects. In addition, it reinforces our position as an expert in the filling of sensitive substances.”